CPSF4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.618400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.911800E-01
Normal-vs-Stage2
9.787600E-01
Normal-vs-Stage3
5.163400E-01
Normal-vs-Stage4
7.408000E-01
Stage1-vs-Stage2
9.815200E-01
Stage1-vs-Stage3
4.413600E-01
Stage1-vs-Stage4
7.144400E-01
Stage2-vs-Stage3
4.137400E-01
Stage2-vs-Stage4
7.290400E-01
Stage3-vs-Stage4
6.962000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.632200E-01
Normal-vs-AfricanAmerican
8.247600E-01
Normal-vs-Asian
9.996400E-01
Caucasian-vs-AfricanAmerican
6.891000E-01
Caucasian-vs-Asian
9.309600E-01
AfricanAmerican-vs-Asian
7.266400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.393000E-01
Normal-vs-Female
9.751600E-01
Male-vs-Female
9.597600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.104400E-01
Normal-vs-Age(41-60Yrs)
7.684600E-01
Normal-vs-Age(61-80Yrs)
6.556600E-01
Normal-vs-Age(81-100Yrs)
9.856200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.639600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.620600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.769000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.706000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.346800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.162390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.950000E-01
Normal-vs-Daily Drinker
9.063400E-01
Normal-vs-Weekly Drinker
9.189400E-01
Normal-vs-Occasional Drinker
7.578600E-01
Normal-vs-Social Drinker
9.609000E-01
Non Drinker-vs-Daily Drinker
1.564200E-01
Non Drinker-vs-Weekly Drinker
4.322200E-01
Non Drinker-vs-Occasional Drinker
2.490600E-01
Non Drinker-vs-Social Drinker
3.025800E-01
Daily Drinker-vs-Weekly Drinker
6.841000E-01
Daily Drinker-vs-Occasional Drinker
5.091200E-01
Daily Drinker-vs-Social Drinker
9.368600E-01
Weekly Drinker-vs-Occasional Drinker
4.193800E-01
Weekly Drinker-vs-Social Drinker
8.077200E-01
Occasional Drinker-vs-Social Drinker
5.083800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.831200E-01
Normal-vs-Grade 2
9.480200E-01
Normal-vs-Grade 3
6.518800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.346800E-01
Grade 1-vs-Grade 3
6.149600E-02
Grade 1-vs-Grade 4
9.831200E-01
Grade 2-vs-Grade 3
7.785600E-02
Grade 2-vs-Grade 4
9.480200E-01
Grade 3-vs-Grade 4
6.518800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.826800E-01
Normal-vs-NonDiabetic
9.511200E-01
Diabetic-vs-NonDiabetic
7.529800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.256000E-01
Normal-vs-NoPancreatitis
9.334400E-01
Pancreatitis-vs-NoPancreatitis
3.056600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.530200E-01
Normal-vs-N1
9.562200E-01
N0-vs-N1
7.875800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.248000E-01
Normal-vs-TP53-NonMutant
8.255600E-01
TP53-Mutant-vs-TP53-NonMutant
3.760200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
